Inaktiver Wert

Andere Sprachen Puma Biotechnology Inc OTC Bulletin Board

Aktien

PBYI

US74587V1070

PBYI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)	07.06.
Puma Biotechnology : Corporate Presentation	03.06.
Puma Biotechnology Announces Presentation of Findings from a Phase I/Ib Study of Alisertib in Advanced EGFR-Mutated Lung Cancer	03.06.
Puma Biotechnology, Inc. Announces Presentation of Findings from A Phase II Study of Alisertib in Endocrine-Resistant Metastatic Breast Cancer (Tbcrc 041)	02.06.
Puma Biotechnology Announces Presentation of Findings from a Phase II Study of Alisertib in Endocrine-Resistant Metastatic Breast Cancer (TBCRC 041)	02.06.
Puma Biotechnology to Join Russell 3000 Index	28.05.
Puma Biotechnology Announces Publication of Alisertib Abstract Titles for the 2024 ASCO Annual Meeting	23.05.
Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial	17.05.
Puma Biotech: Q1 Earnings Snapshot	02.05.
Puma Biotechnology Reports First Quarter Financial Results	02.05.
Puma Biotechnology, Inc. Provides Earnings Guidance for the Second Quarter of Full Year of 2024	02.05.
Puma Biotechnology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	02.05.
Puma Biotechnology to Host Conference Call to Discuss First Quarter 2024 Financial Results	18.04.
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(4)	04.04.
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)	03.04.
Puma Biotechnology Plans to Start Breast Cancer Combination Study in Second Half; Shares Rise	20.03.
Puma Biotechnology Announces FDA Allowance to Proceed Under IND for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer	20.03.
Puma Biotechnology, Inc. Announces FDA Allowance to Proceed Under IND for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer	20.03.
Puma Biotechnology : Corporate Presentation	06.03.
Puma Biotech: Q4 Earnings Snapshot	29.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Puma Biotechnology Inc OTC Bulletin Board

Aktien

PBYI

US74587V1070

PBYI

Andere Sprachen

Filter